Literature DB >> 17485108

Early growth response-1 mediates up-regulation of telomerase in placenta.

O Akutagawa1, H Nishi, S Kyo, C Higuma, M Inoue, K Isaka.   

Abstract

Telomerase is thought to play a very important role in oncogenesis. It is also believed to wind back the "mitotic clock" which leads to ageing and enable permanent cell division. We evaluated telomerase activity in chorionic tissues, with particular attention to the early growth response-1 (EGR-1) gene, the importance of what was recently shown by Khachigian et al. We started our study by evaluating the relationship between activation of transcription of the human telomerase reverse transcriptase (hTERT) gene and EGR-1 gene. For this purpose, we first evaluated telomerase activity using the villous cancer cell lines JAR and JEG-3. We then demonstrated that EGR-1 plays an important role in activation of the transcription of hTERT by luciferase assay using hTERT promoter constructs. As a result of further computer analysis, we discovered a site postulated to be an EGR-1 consensus binding site at -273 to -281 in the hTERT promoter region. With forced expression of EGR-1, an increase in hTERT protein concentration was detected on Western blot analysis, while marked high expression of hTERT mRNA was observed by reverse transcriptase polymerase chain reaction. Furthermore, we evaluated the expression of EGR-1 and hTERT at the mRNA level in the placenta during the first, second and third trimesters of pregnancy and in patients with preeclampsia. Expression of EGR-1 and hTERT in the chorion increased in the first trimester of pregnancy and decreased later. Increased expression was noted in the placenta of patients with preeclampsia. The present findings suggest that EGR-1 plays an important role in activating the transcription of hTERT, showing that activation of the transcription of hTERT by EGR-1 is involved in the trophoblast growth mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485108     DOI: 10.1016/j.placenta.2007.03.005

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  6 in total

1.  A triad of telomerase, androgen receptor and early growth response 1 in prostate cancer cells.

Authors:  Sheeba Jacob; Sumeet Nayak; Ruchi Kakar; Uddhav K Chaudhari; Dolly Joshi; Babu R Vundinti; Gwendolyn Fernandes; Ram S Barai; Sanjeeva D Kholkute; Geetanjali Sachdeva
Journal:  Cancer Biol Ther       Date:  2016-04-02       Impact factor: 4.742

2.  Coxiella burnetii, the agent of Q fever, replicates within trophoblasts and induces a unique transcriptional response.

Authors:  Amira Ben Amara; Eric Ghigo; Yannick Le Priol; Catherine Lépolard; Suzana P Salcedo; Emmanuel Lemichez; Florence Bretelle; Christian Capo; Jean-Louis Mege
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

Review 3.  Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene.

Authors:  Muhammad Khairul Ramlee; Jing Wang; Wei Xun Toh; Shang Li
Journal:  Genes (Basel)       Date:  2016-08-18       Impact factor: 4.096

4.  Sex differences in the late first trimester human placenta transcriptome.

Authors:  Tania L Gonzalez; Tianyanxin Sun; Alexander F Koeppel; Bora Lee; Erica T Wang; Charles R Farber; Stephen S Rich; Lauren W Sundheimer; Rae A Buttle; Yii-Der Ida Chen; Jerome I Rotter; Stephen D Turner; John Williams; Mark O Goodarzi; Margareta D Pisarska
Journal:  Biol Sex Differ       Date:  2018-01-15       Impact factor: 5.027

5.  Maternal human telomerase reverse transcriptase variants are associated with preterm labor and preterm premature rupture of membranes.

Authors:  Caroline Marrs; Kevin Chesmore; Ramkumar Menon; Scott Williams
Journal:  PLoS One       Date:  2018-05-17       Impact factor: 3.240

6.  Alternative lengthening of telomeres is mechanistically linked to potential therapeutic vulnerability in the stem-like subtype of gastric cancer.

Authors:  Ji-Yong Sung; Jae-Ho Cheong
Journal:  Clin Transl Med       Date:  2021-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.